Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

TECH is gaining ground in cell and gene therapy, and with Ella, while navigating macro hurdles. Is it the right fit for your portfolio today?

Trump’s meddling is reaching into nearly every facet of economic life. But today’s CEOs stay quiet.

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient testing solutions for critical care, today provided a 2025 mid-year ...

How to Write the Management Team Section of a Business Plan ... can make the biography more interesting and emphasize the employee's expertise and knowledge. For example, "Margot is the author ...

Scentian Bio is using biosensors inspired by insects to help kiwifruit giant Zespri determine the optimal time to harvest its ...

Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL ...

Automotive OEMs are racing towards a future that needs to combine cutting-edge efficiency with first-class green credentials.

Ron Chernow's new biography covers his literary adventures and also his bad business investments ... The museum has examples of some of the machines Twain invested in as part of its permanent ...

Automotive Die-casting Lubricants Market Bio-based die-casting lubricants are emerging as eco-friendly, high-performance solutions for prec ...